𝔖 Bobbio Scriptorium

✦ LIBER ✦

A retrospective analysis of major determinants of heart failure mortality in patients receiving both ACE inhibitors and Beta-blockers in Val-HeFT

✍ Scribed by Inder S. Anand; Robert Glazer; Yann-Tong Chiang; Allen Hester; Nora Aknay; Jay N. Cohn

Book ID: 119588397
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 60 KB
Volume: 9
Category: Article
ISSN: 1532-8414
DOI: 10.1016/s1071-9164(03)00140-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

821-1 Should beta-blockers be used befor

821-1 Should beta-blockers be used before angiotensin converting enzyme inhibitors in patients with chronic heart failure? Meta-analysis of the prognostic benefit conferred by beta-blockers in patients not receiving ACE inhibitors

✍ Henry Krum; Steven Haas; Jalal Ghali; Edward Gilbert; Phillipe Lechat; Mary-Ann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Valsartan reduces morbidity in people wi

Valsartan reduces morbidity in people with heart failure receiving a low dose of ACE inhibitor and no beta-blocker

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Use of ACE Inhibitors / Angiotensive Rec

Use of ACE Inhibitors / Angiotensive Receptor Blockers and Beta Blockers in Patients with Systolic Heart Failure with Associated Diagnosis of Chronic Kidney Disease

✍ Michael A. Hanna; Veronica Sumodi; Karen Fagnilli 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Does the magnitude of the beneficial eff

Does the magnitude of the beneficial effect of beta-blockers in chronic heart failure differ between diabetic and nondiabetic patients? A meta-analysis of all-cause mortality outcomes from major chronic heart failure beta-blocker trials

✍ Steven Haas; Theo Vos; Richard Gilbert; Henry Krum 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Meta-analyses of mortality and morbidity

Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a β-blocker)

✍ Konstantinos Dimopoulos; Tushar V. Salukhe; Andrew J.S. Coats; Jamil Mayet; Mass 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Review finds combining angiotensin recep

Review finds combining angiotensin receptor blockers with ACE inhibitors in heart failure may only benefit people with contraindications to β blockers: Abstracted from: Dimopoulos K, Salukhe TV, Coats AJ, et al. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol 2004; 93(2–3): 105–11.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB